1 year return (CAGR)
-0.94%
Gyre Therapeutics Inc. Exchange (NASDAQ, USD)
GYRE
7.35
-0.03 (-0.40%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-0.45%
5 year return (CAGR)
-37.22%
10 year return (CAGR)
-30.77%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
784.65M
Price/Sales
6.57
Ent value
775.70M
Price/Book
4.76
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 7.50 |
| Daily high | 7.50 |
| Daily low | 7.04 |
| Daily Volume | 165K |
| All-time high | 47155.50 |
| 1y analyst estimate | 18.67 |
| Beta | 4.82 |
| EPS (TTM) | -0.17 |
| Dividend per share | 0.00 |
| Ex-div date | 13 Jan 2023 |
| Next earnings date | 31 Mar 2026 |
Downside potential
Loading...
Downside potential data
| GYRE | S&P500 | |
| Current price drop from All-time high | -99.98% | -0.84% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 28 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -76.66% | -10.68% |
| Avg time to new high | 89 days | 12 days |
| Max time to new high | 3913 days | 1805 days |
News
